SCOTUS mulls deceptive-intent standard in False Claims Act suits
2023 HEADBRF 0027
By Katie Pasek
WESTLAW Health Daily Briefing
April 20, 2023
(April 20, 2023) - The U.S. Supreme Court has heard oral arguments in a dispute over whether pharmacies accused of overcharging Medicare and Medicaid can avoid False Claims Act liability by arguing their conduct was supported by an "objectively reasonable" interpretation of the law.
United States et al. ex rel. Schutte et al. v. SuperValu Inc. et al., No. 21-1326; United States et al. ex rel. Proctor v. Safeway Inc., No. 22-111, oral argument held (U.S. Apr. 18, 2023).
During the April 18 session, the high court considered what it means to submit a false claim "knowingly," or with scienter, under the FCA, 31 U.S.C.A. § 3729(b)(1)(A), in cases of legal falsity.
Three whistleblowers say two pharmacies overcharged the government by failing to account for customer discounts.
They are asking the high court to reverse two 7th U.S. Circuit Court of Appeals decisions that the pharmacies did not act with deceptive intent when they used an "objectively reasonable" interpretation of the regulatory term "usual and customary price" when seeking prescription drug reimbursement.
Whistleblowers Tracy Schutte and Michael Yarberry petitioned the high court to hear a suit they filed against SuperValu Inc. The Supreme Court consolidated their case with one filed by Thomas Proctor against Safeway Inc.
For more information about the facts and procedural history, please read: .

Objective vs. subjective intent

During oral argument, some of the justices sought to clarify the petitioners' question of whether subjective knowledge is a factor in determining liability under the FCA.
"We're being asked whether the intent of someone to make a false statement is actionable even if later they come up with a different — an objectively reasonable argument, correct?" Associate Justice Sonia Sotomayor asked Tejinder Singh of Sparacino PLLC, who argued for the petitioners and replied in the affirmative.
Arguing for the pharmacies, Carter G. Phillips of Sidley Austin LLP said, "The right answer to this case is that our clients followed an undeniably objectively reasonable approach in what they did."
Associate Justice Ketanji Brown Jackson questioned his emphasis on "objectively reasonable."
"You say it doesn't matter, subjective intent to evaluate actual knowledge for the purpose of the FCA," she said.
Phillips agreed.
Associate Justice Elena Kagan asked, "Don't you think it's a little odd to read a statute … like this to say that … subjectivity doesn't matter?"
Deputy Solicitor General Malcolm L. Stewart, arguing for the federal government as amicus curiae in support of the petitioners, said the pharmacies should have disclosed whether they considered their discounts when they calculated the "usual and customary" drug prices.

Outside attorneys weigh in

According to Brett W. Johnson of Snell & Wilmer LLP, who is not involved in the suits, the 7th Circuit decisions are "likely in peril."
"It appears the majority of the [Supreme] Court is persuaded that an argument about the lack of government guidance on regulatory compliance is best suited to go to the subjective intent element and what the actors knew or did not know at the time of the act," he said.
According to J. William Eshelman of Clark Hill PLC, also not involved in the suits, "The [Supreme] Court apparently took these cases up as a means of resolving the considerable disagreement in the circuits concerning [the FCA's knowledge] requirement, and to establish a uniform standard applicable to the FCA's knowledge requirement."
David J. Chizewer of Goldberg Kohn Ltd., who is not involved in the cases, said that discussion of "what should be expected from persons doing business with the government" was significant.
"At least one justice found it 'extreme' to hold a contractor to such a standard," Chizewer said. "Yet, that would seem to be the bare minimum of what we, as a society, should expect from each other."
By Katie Pasek

Related articles

Related Articles from Westlaw Health Law Daily Briefing
Article: Whistleblowers urge SCOTUS to rule subjective 'knowledge' key for FCA fraud 2023 HEADBRF 0022
Date: April 11, 2023
Three whistleblowers are asking the U.S. Supreme Court to rule that multiple grocery pharmacy operators violated the False Claims Act because they "knowingly" overbilled Medicare and Medicaid for prescription drugs by failing to account for customer discounts.
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.